← Back to Clinical Trials
Recruiting NCT06048172
Effectiveness of Trauma Therapy Using Prolonged Exposure for Patients With PTSD and a Comorbid Psychotic Disorder
Trial Parameters
Condition Post Traumatic Stress Disorder
Sponsor Medicalschool Hamburg
Study Type INTERVENTIONAL
Phase N/A
Enrollment 56
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2023-05-15
Completion 2028-05-17
All Conditions
Interventions
Prolonged Exposure
Brief Summary
Psychosis patients with comorbid PTSD will be treated with trauma therapy.
Eligibility Criteria
Inclusion Criteria: * Presence of a psychotic disorder (F20) or affective disorder with psychotic symptoms(F30) according to DSM-5. * comorbid post-traumatic stress disorder (PTSD) according to DSM-5 (CAPS-5 score ≥ 23) * At least 18 years old * Good knowledge of the German language * Willingness to participate in randomisation and trauma-focused therapy Exclusion Criteria: * Changes in neuroleptic or antidepressant therapy within the last 4 weeks (exclusion of drug effects). * Any substance dependence with continued use other than nicotine and/or caffeine dependence. * IQ of 70 or less * Acute suicidality * Pregnant women
Related Trials
NCT06988787
Multifaceted Intervention to Restore Resilience and Overcome Risk
View Trial →
NCT06073886
Personalized Brain Stimulation to Treat Chronic Concussive Symptoms
View Trial →
NCT06048172
Effectiveness of Trauma Therapy Using Prolonged Exposure for Patients With PTSD and a Comorbid Psych
View Trial →